JINGXIN(SZ:002020) Xin Lang Cai Jing·2025-09-09 06:22Core Viewpoint - Jingxin Pharmaceutical's stock price has shown significant growth this year, with a 60.08% increase, despite a recent decline of 2.01% on September 9 [1][2]. Financial Performance - For the first half of 2025, Jingxin Pharmaceutical reported a revenue of 2.017 billion yuan, a year-on-year decrease of 6.20%, and a net profit attributable to shareholders of 388 million yuan, down 3.54% year-on-year [2]. - The company has cumulatively distributed 2.11 billion yuan in dividends since its A-share listing, with 801 million yuan distributed over the past three years [3]. Stock Market Activity - As of September 9, the stock price was 19.96 yuan per share, with a market capitalization of 17.186 billion yuan. The trading volume was 2.12 billion yuan, with a turnover rate of 1.44% [1]. - The stock has appeared on the "Dragon and Tiger List" once this year, with a net buy of 111 million yuan on July 4, accounting for 21.90% of total trading volume [1]. Shareholder Information - As of June 30, 2025, the number of shareholders was 25,700, a slight decrease of 0.11%, with an average of 28,196 shares held per shareholder, an increase of 0.11% [2]. - The fifth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 9.6492 million shares, a decrease of 1.53917 million shares from the previous period [3].